Benzinga | Mar 4, 2021 03:08PM EST

PTC Therapeutics Receives FDA Orphan Designation Status For Treatment Of Hyperphenylalaninemia

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=805320https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=805320